BPA Call W81XWH22A0001-HT942524F0053
- Not listed
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $8,320.00 from the Defense Health Agency on May 4, 2022, with an ultimate completion date of July 31, 2023. This firm fixed-price task order was issued under Harvard Bioscience's single-award, $4.8 million BPA with the Defense Health Agency, which was awarded on the same date with a completion extending through May 3, 2027. The call order...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $93,639.26 firm fixed-price Blanket Purchase Agreement call order from the Defense Health Agency on March 20, 2025, for ferrets with pre-implanted telemetry devices. The award was issued without set-aside designation and represents a task order under Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was originally awarded on May 4, 2022, and extends...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $36,356 firm fixed-price Blanket Purchase Agreement call order by the Defense Health Agency on October 17, 2025, for DSI telemetry system expansion and upgrade work. This task order is issued under Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was originally awarded in May 2022 and extends through May 3, 2027. The BPA serves as an indefinite...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a firm fixed-price BPA call order valued at $133,885.68 by the Defense Health Agency on July 24, 2024, for ferrets with pre-implanted telemetry devices. The award utilizes no set-aside designation and is scheduled for completion by December 16, 2024, with performance occurring at the company's facility in Mounds View, Minnesota. This task order is issued under Harvard Bioscience's single-award...
- Harvard Bioscience Inc., operating through its Data Sciences International (DSI) division, was awarded a $21,591 firm fixed-price call order by the Defense Health Agency on January 14, 2026, for telemetry equipment and software. This award is a task order issued under Harvard Bioscience's existing single-award Blanket Purchase Agreement with the Defense Health Agency valued at $4.8 million (awarded May 4, 2022, with completion date of May 3, 2027). The BPA serves as an indefinite delivery...
- The Defense Health Agency awarded a $235,556.60 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) for the procurement and implantation of L11 and L03 telemetry devices into non-human primates. This award, effective December 31, 2024 with completion targeted for March 27, 2025, will be performed at Aberdeen Proving Ground, Maryland. The contract represents a task order issued under Harvard Bioscience's existing $4.8 million single-award Blanket...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a firm fixed-price call order valued at $24,405.18 under a Blanket Purchase Agreement (BPA) with the Defense Health Agency for implant reagents. The award was issued on May 4, 2022, with an ultimate completion date of March 15, 2024, and performance is scheduled at JBSA Fort Sam Houston, Texas. This contract represents a task order call against the company's larger $4.8 million single-award BPA with the...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $143,577 firm fixed-price Blanket Purchase Agreement (BPA) call order from the U.S. Army Medical Command on July 27, 2022, for telemetry software and systems. The award was issued without a set-aside designation and is scheduled for completion by August 31, 2022. Performance will be conducted at the company's Mounds View, Minnesota facility. This call order represents one task order within Harvard...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $17,910.30 firm fixed-price call order under a Blanket Purchase Agreement with the Defense Health Agency on March 10, 2023. The award covers aerosol equipment to be delivered to Mounds View, Minnesota, with an ultimate completion date of September 30, 2023. This contract represents a non-set-aside procurement issued without a small business set-aside designation. Harvard Bioscience is a self-certified...
- Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $22,386 firm fixed-price call order under the Defense Health Agency's single-award Blanket Purchase Agreement on October 2, 2025. This task order, which carries an ultimate completion date of September 30, 2026, is designated for the closeout and replenishment of supplies spent by a funded project and will be performed at the company's Mounds View, Minnesota facility. The call represents the latest...
- W81XWH22A0001Blanket Purchase Agreement
- W81XWH22A0001-HT942524F0053BPA Call
Harvard Bioscience Inc., operating through its Data Sciences International division, received a $75,394.99 firm fixed-price Blanket Purchase Agreement call order from the Defense Health Agency for the purchase of telemetry transmitter devices used to track the health of research animals, as well as telemetry implant refurbishments and exchanges. The contract, awarded on April 1, 2024, with an ultimate completion date of May 31, 2025, will be performed at Aberdeen Proving Ground in Maryland. This call order is issued under Harvard Bioscience's larger $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, established in May 2022 with a completion date of May 3, 2027, which serves as an indefinite delivery vehicle enabling streamlined procurement of specialized biomedical research solutions for the Defense Health Agency, Army Medical Command, and other military health system partners. Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in advanced physiological monitoring technologies and wireless implantable telemetry systems used in preclinical research. The company has demonstrated extensive federal contracting experience across multiple agencies including the National Institutes of Health, Department of Veterans Affairs, Environmental Protection Agency, and Food and Drug Administration, with individual contract awards historically ranging from approximately $8,300 to $332,036. The broader BPA vehicle under which this call order was issued has generated over $1.5 million in cumulative procurement value to date, supporting the Defense Health Agency and Army Medical Command's critical biomedical research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 10/21/24 | |
| P00001 | Other Administrative Action | $0 | 4/23/24 | |
| Not listed | Not listed | $75.4k | 1/18/24 |